Grace Therapeutics, Inc.
GRCE
$3.16
$0.020.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.86M | 20.01M | 22.13M | 11.06M | 15.17M |
| Total Receivables | 20.00K | 20.00K | 126.00K | 301.00K | 415.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 416.00K | 500.00K | 453.00K | 583.00K | 477.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.30M | 20.53M | 22.71M | 11.94M | 16.06M |
|
|
|||||
| Total Current Assets | 17.30M | 20.53M | 22.71M | 11.94M | 16.06M |
| Net Property, Plant & Equipment | 12.00K | 14.00K | 2.00K | 19.00K | 21.00K |
| Long-term Investments | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
| Goodwill | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
| Total Other Intangibles | 41.13M | 41.13M | 41.14M | 41.13M | 41.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 66.58M | 69.81M | 71.99M | 61.22M | 65.35M |
|
|
|||||
| Total Accounts Payable | 459.00K | 1.34M | 601.00K | 665.00K | 1.68M |
| Total Accrued Expenses | 786.00K | 976.00K | 1.33M | 1.31M | 999.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.25M | 2.32M | 1.93M | 1.97M | 2.67M |
|
|
|||||
| Total Current Liabilities | 1.25M | 2.32M | 1.93M | 1.97M | 2.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.51M | 3.94M | 3.45M | 7.11M | 6.54M |
| Total Liabilities | 3.76M | 6.26M | 5.38M | 9.09M | 9.22M |
|
|
|||||
| Common Stock & APIC | 293.84M | 293.64M | 293.34M | 279.50M | 279.34M |
| Retained Earnings | -224.99M | -224.05M | -220.69M | -221.32M | -217.17M |
| Treasury Stock & Other | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M |
| Total Common Equity | 62.82M | 63.55M | 66.61M | 52.14M | 56.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 62.82M | 63.55M | 66.61M | 52.14M | 56.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 62.82M | 63.55M | 66.61M | 52.14M | 56.13M |
|
|
|||||